114 related articles for article (PubMed ID: 19407975)
21. Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva).
Zhong W; Chebolu S; Darmani NA
Pharmacol Biochem Behav; 2014 May; 120():124-32. PubMed ID: 24631485
[TBL] [Abstract][Full Text] [Related]
22. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
[TBL] [Abstract][Full Text] [Related]
23. Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds.
Depoortère R; Barret-Grévoz C; Bardin L; Newman-Tancredi A
Eur J Pharmacol; 2008 Nov; 597(1-3):34-8. PubMed ID: 18773888
[TBL] [Abstract][Full Text] [Related]
24. Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets.
Van Sickle MD; Oland LD; Mackie K; Davison JS; Sharkey KA
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G566-76. PubMed ID: 12791597
[TBL] [Abstract][Full Text] [Related]
25. The ups and downs of novel antiemetic drugs, part 1: substance P, 5-HT, and the neuropharmacology of vomiting.
Stahl SM
J Clin Psychiatry; 2003 May; 64(5):498-9. PubMed ID: 12755650
[TBL] [Abstract][Full Text] [Related]
26. Antiemetic role of thalidomide in a rat model of cisplatin-induced emesis.
Han ZX; Xu J; Wang HM; Ma J; Sun X; Du XP
Cell Biochem Biophys; 2014 Sep; 70(1):361-5. PubMed ID: 24718779
[TBL] [Abstract][Full Text] [Related]
27. Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret.
Endo T; Minami M; Monma Y; Saito H; Takeuchi M
J Toxicol Sci; 1990 Nov; 15(4):235-44. PubMed ID: 1707101
[TBL] [Abstract][Full Text] [Related]
28. Serotonin-independent model of cisplatin-induced emesis in the ferret.
Rudd JA; Cheng CH; Naylor RJ
Jpn J Pharmacol; 1998 Nov; 78(3):253-60. PubMed ID: 9869258
[TBL] [Abstract][Full Text] [Related]
29. Aprepitant (EMEND): the role of substance P in nausea and vomiting.
Prommer E
J Pain Palliat Care Pharmacother; 2005; 19(3):31-9. PubMed ID: 16219609
[TBL] [Abstract][Full Text] [Related]
30. Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).
Wu W; Bates MA; Bursian SJ; Flannery B; Zhou HR; Link JE; Zhang H; Pestka JJ
Toxicol Sci; 2013 May; 133(1):186-95. PubMed ID: 23457120
[TBL] [Abstract][Full Text] [Related]
31. Effects of talipexole on emesis-related changes in abdominal afferent vagal activity and ileal serotonin metabolism in rats.
Minami M; Nemoto M; Endo T; Hamaue N; Kohno Y
Res Commun Mol Pathol Pharmacol; 1997 Jan; 95(1):67-82. PubMed ID: 9055350
[TBL] [Abstract][Full Text] [Related]
32. [Role of serotonin in emesis].
Minami M; Endo T; Hirafuji M
Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):233-42. PubMed ID: 8974084
[TBL] [Abstract][Full Text] [Related]
33. In vitro release and tissue levels of ileal serotonin after cisplatin-induced emesis in the cat.
Milano S; Simon C; Grélot L
Clin Auton Res; 1991 Dec; 1(4):275-80. PubMed ID: 1822260
[TBL] [Abstract][Full Text] [Related]
34. Effect of 6-hydroxydopamine treatment in the area postrema on morphine-induced emesis in ferrets.
Yoshikawa T; Yoshida N
Jpn J Pharmacol; 2002 Aug; 89(4):422-5. PubMed ID: 12233822
[TBL] [Abstract][Full Text] [Related]
35. Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1.
Hu DL; Zhu G; Mori F; Omoe K; Okada M; Wakabayashi K; Kaneko S; Shinagawa K; Nakane A
Cell Microbiol; 2007 Sep; 9(9):2267-77. PubMed ID: 17517065
[TBL] [Abstract][Full Text] [Related]
36. 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
Higa GM; Auber ML; Altaha R; Piktel D; Kurian S; Hobbs G; Landreth K
J Oncol Pharm Pract; 2006 Dec; 12(4):201-9. PubMed ID: 17156592
[TBL] [Abstract][Full Text] [Related]
37. Emesis: antiemetic effect of cyclophosphamide at central receptors of multitransmitter system in the cat.
Bosnjak S; Beleslin DB
Pharmacol Res; 2002 Nov; 46(5):425-34. PubMed ID: 12419647
[TBL] [Abstract][Full Text] [Related]
38. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
Navari RM; Reinhardt RR; Gralla RJ; Kris MG; Hesketh PJ; Khojasteh A; Kindler H; Grote TH; Pendergrass K; Grunberg SM; Carides AD; Gertz BJ
N Engl J Med; 1999 Jan; 340(3):190-5. PubMed ID: 9917226
[TBL] [Abstract][Full Text] [Related]
39. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
Castejon AM; Paez X; Hernandez L; Cubeddu LX
J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats.
McCarthy LE; Borison HL
Cancer Treat Rep; 1984 Feb; 68(2):401-4. PubMed ID: 6538113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
